TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 6,311 | 5,846 | 6,388 |
Financial expenses | 3 | 7 | 7 |
Earnings before taxes | 1,212 | 1,134 | 2,004 |
EBITDA | 1,211 | 1,140 | 2,016 |
Total assets | 3,326 | 3,114 | 2,516 |
Current assets | 3,326 | 3,114 | 2,516 |
Current liabilities | 566 | 569 | 804 |
Equity capital | 2,759 | 2,545 | 1,707 |
- share capital | 101 | 95 | 98 |
Employees (average) | 2 | 2 | 5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 83.0% | 81.7% | 67.8% |
Turnover per employee | 3,156 | 2,923 | 1,278 |
Profit as a percentage of turnover | 19.2% | 19.4% | 31.4% |
Return on assets (ROA) | 36.5% | 36.6% | 79.9% |
Current ratio | 587.6% | 547.3% | 312.9% |
Return on equity (ROE) | 43.9% | 44.6% | 117.4% |
Change turnover | 51 | -350 | -547 |
Change turnover % | 1% | -6% | -8% |
Chg. No. of employees | 0 | -3 | 0 |
Chg. No. of employees % | 0% | -60% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.